Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of ADMA BIOLOGICS, INC. from Q1 2024 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
Adma Biologics, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q1 2024 to Q1 2025.
- Adma Biologics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending March 31, 2025 was $373M, a 143% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)